FDA panel supports Moderna COVID-19 booster shots for older Americans and other adults at higher risk of infection

FDA panel supports Moderna COVID-19 booster shots for older Americans and other adults at higher risk of infection

FDA panel supports Moderna COVID-19 booster shots for older Americans and other adults at higher risk of infection A federal advisory panel voted Thursday to support booster shots of the Moderna COVID-19 vaccine for people 65 and up, as well as younger adults with certain medical problems or jobs that put them at increased risk for infection. The booster shot will be a half-dose of the same vaccine already given. Company data suggested that the lower dose was as effective but had potentially fewer side effects. The Food and Drug Administration committee, whose decision needs to be verified by a different advisory panel as well as top federal officials, spent Thursday reviewing data about the safety and effectiveness of a third dose of Moderna vaccine, as well as the effect …
More on: www.usatoday.com